Plante Moran Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.4K Buy
642
+6
+0.9% +$536 ﹤0.01% 306
2026
Q1
$45.7K Buy
636
+1
+0.2% +$77 ﹤0.01% 327
2025
Q4
$50.4K Sell
635
-27
-4% -$2.13K ﹤0.01% 325
2025
Q3
$49.9K Buy
662
+27
+4% +$1.85K ﹤0.01% 336
2025
Q2
$43.8K Hold
635
﹤0.01% 359
2025
Q1
$43K Sell
635
-1,247
-66% -$74.6K ﹤0.01% 367
2024
Q4
$84.5K Sell
1,882
-1,010
-35% -$56.7K 0.01% 279
2024
Q3
$182K Sell
2,892
-886
-23% -$51.7K 0.02% 191
2024
Q2
$223K Buy
3,778
+155
+4% +$9.7K 0.02% 162
2024
Q1
$289K Buy
3,623
+999
+38% +$76.3K 0.03% 130
2023
Q4
$207K Buy
2,624
+208
+9% +$14.8K 0.02% 163
2023
Q3
$169K Sell
2,416
-216
-8% -$15.3K 0.02% 164
2023
Q2
$182K Buy
2,632
+723
+38% +$51.4K 0.02% 167
2023
Q1
$142K Sell
1,909
-1,820
-49% -$153K 0.02% 184
2022
Q4
$347K Sell
3,729
-97
-3% -$9.36K 0.05% 102
2022
Q3
$365K Sell
3,826
-12
-0.3% -$1.19K 0.06% 94
2022
Q2
$356K Buy
3,838
+112
+3% +$10.9K 0.06% 99
2022
Q1
$377K Sell
3,726
-199
-5% -$20.9K 0.07% 106
2021
Q4
$405K Sell
3,925
-197
-5% -$18.2K 0.07% 106
2021
Q3
$350K Buy
4,122
+590
+17% +$49.4K 0.08% 128
2021
Q2
$295K Sell
3,532
-1,999
-36% -$164K 0.07% 133
2021
Q1
$416K Sell
5,531
-2,327
-30% -$170K 0.11% 91
2020
Q4
$537K Buy
7,858
+3,138
+66% +$204K 0.17% 74
2020
Q3
$276K Buy
4,720
+100
+2% +$6.22K 0.1% 116
2020
Q2
$300K Sell
4,620
-595
-11% -$37.5K 0.12% 98
2020
Q1
$309K Buy
5,215
+512
+11% +$34.2K 0.14% 89
2019
Q4
$349K Buy
4,703
+587
+14% +$41.2K 0.12% 104
2019
Q3
$260K Sell
4,116
-755
-15% -$44.7K 0.08% 134
2019
Q2
$265K Sell
4,871
-342
-7% -$18.4K 0.08% 122
2019
Q1
$281K Sell
5,213
-186
-3% -$11.5K 0.09% 118
2018
Q4
$354K Buy
5,399
+87
+2% +$6.49K 0.12% 96
2018
Q3
$418K Sell
5,312
-343
-6% -$24.5K 0.14% 87
2018
Q2
$364K Sell
5,655
-204
-3% -$13.4K 0.18% 93
2018
Q1
$364K Sell
5,859
-30
-0.5% -$2.15K 0.2% 92
2017
Q4
$427K Buy
5,889
+454
+8% +$33K 0.24% 78
2017
Q3
$442K Sell
5,435
-552
-9% -$43.7K 0.26% 73
2017
Q2
$482K Sell
5,987
-114
-2% -$9K 0.3% 70
2017
Q1
$479K Sell
6,101
-994
-14% -$79.4K 0.29% 77
2016
Q4
$560K Buy
7,095
+536
+8% +$43.4K 0.35% 62
2016
Q3
$584K Buy
6,559
+425
+7% +$40.1K 0.39% 54
2016
Q2
$587K Buy
6,134
+433
+8% +$43.2K 0.43% 48
2016
Q1
$591K Sell
5,701
-6
-0.1% -$583 0.46% 48
2015
Q4
$558K Buy
5,707
+530
+10% +$51.9K 0.42% 56
2015
Q3
$499K Buy
5,177
+130
+3% +$13.7K 0.39% 58
2015
Q2
$529K Hold
5,047
0.38% 56
2015
Q1
$521K Sell
5,047
-170
-3% -$17.2K 0.36% 63
2014
Q4
$502K Buy
5,217
+1,526
+41% +$134K 0.37% 57
2014
Q3
$294K Buy
3,691
+258
+8% +$20.3K 0.26% 70
2014
Q2
$259K Buy
3,433
+657
+24% +$49.7K 0.23% 72
2014
Q1
$208K Sell
2,776
-2,214
-44% -$156K 0.23% 70
2013
Q4
$357K Buy
4,990
+1,239
+33% +$79.6K 0.2% 63
2013
Q3
$213K Buy
3,751
+999
+36% +$59.5K 0.13% 69
2013
Q2
$157K Buy
+2,752
New +$159K 0.12% 78

Other funds holding CVS

Plante Moran Financial Advisors's CVS Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its CVS Health (CVS) stake by 0.94% in Q2 2026, buying an estimated $536 and bringing the position to 642 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Plante Moran Financial Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $591K in Q1 2016. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Plante Moran Financial Advisors held 642 shares of CVS Health worth $66.4K as of Q2 2026.
  • Plante Moran Financial Advisors bought 6 CVS Health shares in Q2 2026, an estimated $536.
  • CVS Health made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #306 holding.
  • Plante Moran Financial Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Plante Moran Financial Advisors's CVS Health position peaked at $591K in Q1 2016.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.